Related Experiment Video
Updated: Apr 16, 2026

08:16
Comparative Lesions Analysis Through a Targeted Sequencing Approach
Published on: November 5, 2019
7.4K
Metastatic Basal Cell Carcinoma With Unusual Molecular Genetics Findings
Noora Al-Hail1, Majid Al-Abdulla2, Syed Rizvi3
1Department of Otolaryngology-Head and Neck Surgery Hamad Medical Corporation Doha Qatar.
Clinical Case Reports
|April 15, 2026
Summary
This case study details a rare basal cell carcinoma (BCC) metastasis to cervical lymph nodes. It highlights diagnostic challenges and unique molecular findings (HMGA2-CHMP1A fusion, CDKN2B mutation) in advanced BCC.
Area of Science:
- Oncology
- Dermatology
- Molecular Pathology
Background:
- Basal cell carcinoma (BCC) rarely metastasizes, typically to regional lymph nodes.
- Head and neck BCCs are known to spread to cervical lymph nodes.
- Metastatic BCC presents significant diagnostic and therapeutic challenges.
Purpose of the Study:
- To report a rare case of basal cell carcinoma with cervical lymph node metastasis.
- To describe the diagnostic and management complexities of this presentation.
- To highlight unique molecular findings in a metastatic BCC case.
Main Methods:
- Case presentation of a slow-growing scalp BCC with level V cervical lymph node metastasis.
- Surgical management including lesion excision and neck dissection.
- Adjuvant chemotherapy with Vismodegib and molecular pathology analysis.
- Post-operative imaging and multi-disciplinary team (MDT) follow-up.
Main Results:
- Diagnosis of BCC with pre-existing metastasis to level V cervical lymph nodes.
- Identification of HMGA2-CHMP1A gene fusion and CDKN2B PTC mutation.
- Post-operative finding of a potentially inflammatory nodule in level IIB lymph nodes.
- Ongoing MDT evaluation for level IIB lymph nodes.
Conclusions:
- Metastatic BCC, though rare, necessitates thorough diagnostic evaluation and tailored treatment.
- Unique molecular profiles may be associated with aggressive BCC.
- Close follow-up is crucial for managing potential recurrence or metastasis in challenging BCC cases.
More Related Videos
Related Concept Videos
Metastasis
7.0K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
7.0K
Cancers Originate from Somatic Mutations in a Single Cell
15.7K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.7K

